Pigment epithelium-derived factor: A not so sympathetic regulator of insulin resistance?

Exercise and Sport Sciences Reviews

Volumn 39, Issue 4, 2011, Pages 187-190

  Bell, Christopher ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM DERIVED FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ANIMAL; ARTICLE; BLOOD; HUMAN; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; EYE PROTEINS; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL; NERVE GROWTH FACTORS; RECEPTOR CROSS-TALK; SERPINS; SYMPATHETIC NERVOUS SYSTEM;

EID: 80053359376     PISSN: 00916331     EISSN: None     Source Type: Journal    
DOI: 10.1097/JES.0b013e31822673f0     Document Type: Article

References (35)

1. Banumathi E, Sheikpranbabu S, Haribalaganesh R, Gurunathan S. PEDF prevents reactive oxygen species generation and retinal endothelial cell damage at high glucose levels. Exp. Eye Res. 2010; 90:89-96.
2. Borg ML, Andrews ZB, Duh EJ, Zechner R, Meikle PJ, Watt MJ. Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes. 2011; 60:1458-66.
3. Chen C, Tso AW, Law LS, et al. Plasma level of pigment epithelium- derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study. J. Clin. Endocrinol. Metab. 2010; 95:5074-81.
4. Crowe S, Wu LE, Economou C, et al. Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metab. 2009; 10:40-7.
5. Elayappan B, Ravinarayannan H, Pasha SP, Lee KJ, Gurunathan S. PEDF inhibits VEGF- and EPO-induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation. Angiogenesis. 2009; 12:313-24.
6. Famulla S, Lamers D, Hartwig S, et al. Pigment epithelium-derived factor is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells. Int. J. Obes. (Lond.). 2011; 35(6):762-72.
7. Franck N, Gummesson A, Jernas M, et al. Identification of adipocyte genes regulated by caloric intake. J. Clin. Endocrinol. Metab. 2011; 96: E413-8.
8. Ho TC, Chen SL, -ang -C, Liao CL, Cheng HC, Tsao -P. PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc. Res. 2007; 76:213-23.
9. Jenkins A, Zhang SX, Gosmanova A, et al. Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res. Clin. Pract. 2008; 82:e5-7.
10. Kennedy A, Martinez K, Chuang CC, LaPoint K, McIntosh M. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J. Nutr. 2009; 139:1-4.
11. Kivela R, Silvennoinen M, Lehti M, Jalava S, Vihko V, Kainulainen H. Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice. Cardiovasc. Diabetol. 2008; 7:13.
12. Lashbrook BL, Steinle JJ. Beta-adrenergic receptor regulation of pigment epithelial-derived factor expression in rat retina. Auton. Neurosci. 2005; 121:33-9. (Pubitemid 41254051)
13. Lloyd PG, Prior BM, Li H, -ang HT, Terjung RL. VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats. Am. J. Physiol. Heart Circ. Physiol. 2005; 288:H759-68. (Pubitemid 40139661)
14. Manalo KB, Choong PF, Becerra SP, Dass CR. Pigment epithelium- derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective. Expert Opin. Ther. Pat. 2011; 21:121-30.
15. Manalo KB, Choong PF, Dass CR. Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factordriven tumor-angiogenesis. Mol. Carcinog. 2011; 50:67-72.
16. Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita -, Imaizumi T. Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension. Int. J. Cardiol. 2010; 143:96-8.
17. Newsom SA, Richards JC, Johnson TK, et al. Short-term sympathoadrenal inhibition augments the thermogenic response to beta-adrenergic receptor stimulation. J. Endocrinol. 2010; 206:307-15.
18. Notari L, Baladron V, Aroca-Aguilar JD, et al. Identification of a lipaselinked cell membrane receptor for pigment epithelium-derived factor. J. Biol. Chem. 2006; 281:38022-37. (Pubitemid 46042106)
19. Ogata N, Matsuoka M, Matsuyama K, et al. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. J. Clin. Endocrinol. Metab. 2007; 92:1176-9. (Pubitemid 46465700)
20. Pedersen BK. Muscle-to-fat interaction: a two-way street? J. Physiol. 2010; 588:21.
21. Richards JC, Johnson TK, Kuzma JN, et al. Short-term sprint interval training increases insulin sensitivity in healthy adults but does not affect the thermogenic response to beta-adrenergic stimulation. J. Physiol. 2010; 588:2961-72.
22. Rychli K, Niessner A, Hohensinner PJ, et al. Prognostic value of pigment epithelium-derived factor in advanced heart failure patients. Chest. 2010; 138:656-64.
23. Sabater M, Moreno-Navarrete JM, Ortega FJ, et al. Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J. Clin. Endocrinol. Metab. 2010; 95:4720-8.
24. Schiffelers SL, Saris WH, Boomsma F, van Baak MA. Beta(1)- and beta(2)-adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. J. Clin. Endocrinol. Metab. 2001; 86:2191-9. (Pubitemid 32472939)
25. Sitnick M, Bodine SC, Rutledge JC. Chronic high fat feeding attenuates load-induced hypertrophy in mice. J. Physiol. 2009; 587:5753-65.
26. Steinle JJ, Cappocia FC Jr, Jiang -. Beta-adrenergic receptor regulation of growth factor protein levels in human choroidal endothelial cells. Growth Factors. 2008; 26:325-30. (Pubitemid 352781845)
27. Stejskal D, Karpisek M, Svestak M, Hejduk P, Sporova L, Kotolova H. Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population. J. Clin. Lab. Anal. 2010; 24:17-9.
28. Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium- derived factor with potent neuronal differentiative activity. Exp. Eye Res. 1991; 53:411-4.
29. Tschoner A, Sturm W, Ress C, et al. Effect of weight loss on serum pigment epithelium-derived factor levels. Eur. J. Clin. Invest. 2011. [Epub ahead of print].
30. Umei H, Yamagishi SI, Imaizumi T. Positive association of serum levels of pigment epithelium-derived factor with high-sensitivity C-reactive protein in apparently healthy unmedicated subjects. J. Int. Med. Res. 2010; 38:443-8.
31. Wang P, Smit E, Brouwers MC, et al. Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depot. Eur J Endocrinol. 2008; 159:713-8.
32. Yamagishi S, Adachi H, Abe A, et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J. Clin. Endocrinol. Metab. 2006; 91:2447-50. (Pubitemid 43855041)
33. Yamagishi SI, Matsui T. Anti-atherothrombogenic properties of PEDF. Curr. Mol. Med. 2010; 10:284-91.
34. Yoshida T, Yamagishi S, Nakamura K, et al. Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE) -induced hepatic insulin resistance in vitro by suppressing Rac-1 activation. Horm. Metab. Res. 2008; 40:620-5.
35. Zhang SX, Wang JJ, Dashti A, et al. Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein. J. Mol. Endocrinol. 2008; 41:135-43.